Hepatitis C virus (HCV) core antigen kinetics during treatment of chronic hepatitis C with interferon alpha and/or ribavirin.

被引：0
|
作者：
Dahari, H
Hezode, C
Bouvier-Alias, M
Dhumeaux, D
Neumann, AU
Pawlotsky, JM
机构：
[1] Bar Ilan Univ, Bar Ilan, Israel
[2] Hop Henri Mondor, F-94010 Creteil, France
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
176
引用
收藏
页码：217A / 217A
页数：1
相关论文
共 50 条
  • [21] Combination therapy with ribavirin and alpha interferon for the treatment of chronic hepatitis C refractory to interferon
    Cozzolongo, R
    Cuppone, R
    Giannuzzi, V
    Amati, L
    Caradonna, L
    Tamborrino, V
    Jirillo, E
    Manghisi, OG
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (01) : 129 - 135
  • [22] Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin
    Onyike, CU
    Bonner, JO
    Lyketsos, CG
    Treisman, GJ
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (03): : 429 - 435
  • [23] Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin
    Ridruejo, Ezequiel
    Christensen, Alejo Florin
    Mando, Oscar G.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (06) : 693 - 694
  • [24] Combination treatment with consensus-interferon and ribavirin for chronic hepatitis C patients with non-response relapse to previous treatment with alpha-interferon and ribavirin.
    Buggisch, P
    Seegers, B
    Hinrichsen, H
    Hueppe, D
    Reiser, M
    de Heer, G
    Wursthorn, K
    Sterneck, M
    [J]. HEPATOLOGY, 2002, 36 (04) : 363A - 363A
  • [25] Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C
    Kemp, William
    Roberts, Stuart
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 137 - 150
  • [26] Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin
    Christine J. Weegink
    Robert A. F. M. Chamuleau
    Henk W. Reesink
    Delmar S. M. Molenaar
    [J]. Journal of Gastroenterology, 2001, 36 : 723 - 724
  • [27] Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin
    Gombosova, L.
    Jarcuska, P.
    Benova, B.
    Benicky, M.
    Lazurova, I
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2011, 112 (06): : 360 - 362
  • [28] Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin
    Weegink, CJ
    Chamuleau, RAFM
    Reesink, HW
    Molenaar, DSM
    [J]. JOURNAL OF GASTROENTEROLOGY, 2001, 36 (10) : 723 - 724
  • [29] Efficacy of high dose consensus interferon for the treatment of chronic hepatitis C non responders to interferon alpha 2b and ribavirin.
    Moskovitz, DN
    Manoharan, P
    Heathcote, J
    [J]. HEPATOLOGY, 2001, 34 (04) : 577A - 577A
  • [30] Retreatment of chronic hepatitis C with ribavirin followed by alpha interferon
    Bellobuono, A
    Mondazzi, L
    Tempini, S
    Silini, E
    Vicari, F
    Asti, L
    Zavaglia, C
    Ideo, G
    [J]. HEPATOLOGY RESEARCH, 1997, 7 (02) : 121 - 129
12345